Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2
Nick Orr(United States Department of Health and Human Services), U. Hamann, Marjanka K. Schmidt(University of Cambridge), Peter A. Fasching(Universitätsklinikum Erlangen), J. L. Hopper, Helen R. Warren(Queen Mary University of London), Frank Dudbridge(University of Cambridge), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Thérèse Truong(Université Paris-Sud), Annegien Broeks, Nicola H. Dryden(Institute of Cancer Research), F Marmé(Heidelberg University), Pascal Guénel(Inserm), Ian Tomlinson(University of Oxford), Arif B. Ekici(University Medical Center Groningen), Evangelos Perrakis(Breast Cancer Research Foundation), Javier Benı́tez(Spanish National Cancer Research Centre), Sarah Maguire(Breast Cancer Now), Susan L. Neuhausen(City of Hope), Jennifer Stone(North Carolina State University), José Ignacio Arias Pérez, Elinor J. Sawyer(King's College London), Nicola Johnson(University of Cambridge), Maya Ghoussaini(Regeneron (United States)), Simon Feldbæk Nielsen(Population Council), Stig E. Bojesen(University of Copenhagen), M. Pilar Zamora(Universidad Autónoma de Madrid), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Børge G. Nordestgaard(Gentofte Hospital), Christof Sohn, Daniela Novo(Breast Cancer Research Foundation), Aida Karina Dieffenbach(German Cancer Research Center), Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Zoe Aitken(Melbourne Health), María‐José Sánchez(Instituto de Investigación Biosanitaria de Granada), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, Frans B.L. Hogervorst(The Netherlands Cancer Institute), C Stegmaier(Krebsregister Saarland), Laura J. van’t Veer(University of California, San Francisco), L.J. Gibson(National Institutes of Health), Carmel Apicella(The University of Melbourne), Henrik Flyger(Herlev Hospital), Nicola Miller(Ollscoil na Gaillimhe – University of Galway), Lothar Haeberle(Friedrich-Alexander-Universität Erlangen-Nürnberg), Pablo Menéndez(Parque Tecnológico de la Salud), E. Cordina-Duverger(Université Paris-Sud), Volker Arndt(German Cancer Research Center)
Cited by 48
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k